ELV

Elevance Health Down 7% On Lower Q2 Profit

(RTTNews) - Elevance Health Inc. (ELV) shares are sliding more than 7 percent on Wednesday morning trade after the company reported a decline in second-quarter earnings.

Net income for the quarter declined 8.4 percent to $1.65 billion from $1.80 billion last year. Earnings per declined to 243.4 compared to 247.4 a year ago.

Currently, shares are at $464.75, down 6.57 percent from the previous close of $497.43 on a volume of 284,643. For the 52-week period, the shares have traded in a range of $355.43-$533.68 on average volume of 1,111,637.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

More Related Articles

Info icon

This data feed is not available at this time.

Data is currently not available

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.